Latest Technetium Stories

VANCOUVER, June 9, 2013 /CNW/ - With Canadian-developed tools and technology, a national team led by TRIUMF has reached a crucial milestone at the BC Cancer Agency in developing and deploying alternatives for supplying key medical isotopes. The team used a medical cyclotron that was designed and manufactured by Advanced Cyclotron Systems, Inc. (ACSI) of Richmond, BC, and successfully achieved large-scale production of technetium-99m (Tc-99m), sufficient for a metropolitan area....

Researchers produce molybdenum-99 from irradiation of low-enriched uranium solution LOS ALAMOS, N.M., May 13, 2013 /PRNewswire-USNewswire/ -- Today, Los Alamos National Laboratory announced that for the first time, irradiated uranium fuel has been recycled and reused for molybdenum-99 (Mo-99) production, with virtually no losses in Mo-99 yields or uranium recovery. This demonstrates the viability of the separation process, as well as the potential for environmentally- and...

A University of Alberta team has made an important breakthrough in the race to find a viable replacement for supply of technetium-99m, an important isotope produced by Canada's Chalk River reactor. Their research has proven that this important medical isotope, used in nuclear medicine imaging for about 250,000 Alberta patients each year, can be created in a device known as a cyclotron—and is as safe to use and provides as reliable an image as reactor-based isotopes. Their results are a...

MONTREAL, May 28, 2012 /PRNewswire/ - We are pleased to announce the appointment of Mr. Martyn Coombs as President, Jubilant DraxImage Inc. at Montreal, Canada with effect from May 23, 2012. Prior to joining Jubilant DraxImage, Mr. Coombs served as CEO of Asterand PLC from 2007 to 2011. During his term, he received an award from the Financial Times for the top performing stock on the London Stock Exchange, out of over 2,000 companies. Previously, he served in Japan for five...

While the costs associated with storing nuclear waste and the possibility of it leaching into the environment remain legitimate concerns, they may no longer be obstacles on the road to cleaner energy. A new paper by researchers at the University of Notre Dame, led by Thomas E. Albrecht-Schmitt, professor of civil engineering and geological sciences and concurrent professor of chemistry and biochemistry, showcases Notre Dame Thorium Borate-1 (NDTB-1) as a crystalline compound which can be...

ORLANDO, Fla., Feb. 23, 2012 /PRNewswire/ -- Technetium, an Orlando-based brand marketing agency, was recently recognized with a Silver ADDY at the 2012 AAF-Orlando ADDY Awards for their work on the SOUL by Ludacris package design. Technetium's work on the SOUL by Ludacris brand included consumer package design, a global marketing campaign and all support materials for the 2011 U.S. product launch. Technetium's leadership in the design and development of the branding campaign has...

Surgeon Naia Uribe-Etxebarria has used a radioactive substance which, injected into a lung tumour, enables the detection of the path that the carcinoma intends to take in order to propagate itself. Concretely she applied technetium 99 in resectable non-small cell lung cancers (NSCLC) at an early stage (I or II), and in an intraoperative manner. Thanks to this, she detected with precision the sentinel node (SNOL); the primary node or ganglion of cells to receive lymphatic drainage from the...

ATLANTA, June 3, 2011 /PRNewswire/ -- Perma-Fix Environmental Services, Inc. (NASDAQ: PESI) today announced it has signed an exclusive option agreement with Battelle, which operates Pacific Northwest National Laboratory for the U.S. Department of Energy, to license technology from PNNL for use with Perma-Fix's proprietary process to safely and cost-effectively produce Molybdenum-99 (Mo-99), which is used to make Technetium 99m (Tc-99m).Tc-99m is the most widely used medical isotope in...

MDS Nordion secures exclusive Mo-99 supply through framework agreementOTTAWA, Sept. 23 /PRNewswire-FirstCall/ - MDS Nordion, a leading provider of products and services to the global health science market, today announced it has entered into a framework agreement with The Open Joint Stock Company "Isotope" (Isotope), the authorized subsidiary of Rosatom State Corporation, to explore and define areas of collaboration in the field of supply, marketing and sale of isotopes produced in...

Twenty million medical scans and treatments are done each year that require radioactive isotopes, and scientists today described a global shortage of these life-saving materials that could jeopardize patient care and drive-up health care costs. They spoke at a symposium at one of the opening sessions of the 240th National Meeting of the American Chemical Society.Medical isotopes are minute amounts of radioactive substances used to diagnose and treat a variety of diseases. Isotopes injected...